We use cookies to help us improve the website and your experience using it. You may delete and block all cookies from this site at any time. However, please note this may result in parts of the site no longer working correctly. If you continue without changing your settings we will assume you are happy to receive all cookies on this site.

Close

Meningococcal Reference Unit publications

The Meningococcal Reference Unit publishes a number of studies and reports each year. A list of these publications for each year, together with reference information, is also available for download.

2011 publications

Lucidarme J, Newbold LS, Findlow J, Gilchrist S, Gray SJ et al. Molecular targets in meningococci: efficient routine characterisation and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP. Clin Vaccine Immunol 2011; 18:194-202.

Download 2011 publications list (PDF, 19KB)

2010 publications

Foster RA, Carlring J, Lees A, Borrow R, Ramsay M, Kaczmarski E, et al. Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine. Clin Vaccine Immunol 2010; 17: 1104-1110.

Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, et al. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin Vaccine Immunol 2010; 17: 919-929.

Download 2010 publications list (PDF, 19KB)

2009 publications

Darton T, Guiver M, Nayler S, Jack DL, Kaczmarski EB, Borrow R, Read RC. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis 2009; 48: 587-594.

Stanford E, Print F, Falconer M, Lamden K, Ghebrehewet S, Phin N, Baxter D, Helbert M, McCann R, Andrews N, Balmer P, Borrow R, Kaczmarski E. Immune response to pneumococcal conjugate vaccination in asplenic individuals. Human Vaccines 2009; 5: 85-91.

Read RC, Teare DM, Pridmore AC, Naylor SC, Timms JM, Kaczmarski EB, Borrow R, Wilson AG. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009; 4: 1237-1243.

Read RC, Teare DM, Pridmore AC, Naylor SC, Timms JM, Kaczmarski EB, Borrow R, Wilson AG. The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality. Crit Care Med 2009; 37: 1237-1243.

Lucidarme J, Commanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Kugelberg E, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Tang C, Borrow R. Characterization of fHbp, nhba (gna2132), nadA, por A, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales. Journal of Clinical Microbiology 2009; 47: 3577-3585.

Paranthaman K, Kent L, McCarthy N, Gray SJ. Invasive meningococcal disease: completeness and timeliness of reporting of confirmed cases in Thames Valley 2006-2007. Public Health 2009; 123: 805-808.

Muscat M, Spiteri G, Calleja N, Haider J, Gray SJ, Melillo JM, Mamo J, Cuschieri P. Invasive meningococcal disease in Malta: an epidemiological overview 1994 - 2007. J med Microbiol 2009; 58: 1492-1498.

Harrison OB, Evans NJ, Blair JM, Grimes HS, Tinsley CR, Nassif X, Kriz P, Ure R, Gray SJ, et al. Epidemiological evidence for the role of the haemoglobin receptor, hmbR, in meningococcal virulence. J Infect Dis 2009; 200: 94-98.

Download 2009 publications list (PDF, 20KB)